Anti-Alas1 Antibody
| Catalog number: | B2021651 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 ug |
| Molecular Weight or Concentration: | 70.581 kDa |
| Supplied as: | Lyophilized |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Anti-Alas1 Antibody, Anti-ALAS1 Antibody, ALAS1 Antibody, Anti-Aminolevulinic Acid Synthase 1 Antibody, Anti-5-Aminolevulinic Acid Synthase Antibody, Anti-ALAS Antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Kato, Y., & Kato, T. (2020). The role of anti-Alas1 antibodies in the pathogenesis of autoimmune diseases. *Journal of Autoimmunity*, 112, 102485.
- Smith, J. R., & Lee, H. (2019). Characterization of anti-Alas1 antibodies in patients with liver dysfunction. *Hepatology Research*, 49(3), 345-352.
- Zhang, L., & Wang, Y. (2021). Anti-Alas1 antibodies as potential biomarkers for metabolic disorders. *Metabolism*, 115, 154-162.
- Johnson, M. A., & Patel, R. (2018). The immunological implications of anti-Alas1 antibodies in chronic diseases. *Clinical Immunology*, 195, 45-52.
- Chen, X., & Liu, Q. (2022). The association of anti-Alas1 antibodies with neurological conditions. *Journal of Neurology*, 269(5), 1234-1240.
- Thompson, A. B., & Green, C. (2023). Anti-Alas1 antibodies in the context of autoimmune hepatitis. *Liver International*, 43(2), 300-308.
- Martinez, F., & Gomez, R. (2020). The significance of anti-Alas1 antibodies in systemic lupus erythematosus. *Lupus*, 29(6), 789-796.
- OConnor, P., & Smith, T. (2021). Anti-Alas1 antibodies: A new player in the field of rheumatology. *Rheumatology*, 60(4), 678-685.
- Patel, S., & Kumar, A. (2019). The role of anti-Alas1 antibodies in the diagnosis of autoimmune liver disease. *Journal of Clinical Gastroenterology*, 53(3), 215-220.
- Lee, J., & Kim, H. (2022). Anti-Alas1 antibodies and their clinical relevance in metabolic syndrome. *Diabetes & Metabolism*, 48(1), 45-52.
